Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FBPEC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,115
Award facts
- Contract value 100% obligated
- $20,115.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $20,115.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The delivery order, issued on January 22, 2026, with an ultimate completion date of February 12, 2026, carries no set-aside designation, indicating the contractor won this award through unrestricted federal procurement competition. DMS Pharmaceutical Group will perform the work at its Park Ridge headquarters and will serve as the prime contractor with no identified subcontractors on this award.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that authorizes DLA to procure a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. The parent IDC, awarded on November 13, 2025, with a $499.9 million ceiling and completion date of December 31, 2036, positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors capable of fulfilling the diverse pharmaceutical and medical supply requirements of military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FBPEC?
SPE2DR26FBPEC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FBPEC worth?
The government has obligated $20,115 on SPE2DR26FBPEC.
Is contract SPE2DR26FBPEC an order under another contract?
Yes. SPE2DR26FBPEC is a delivery order under SPE2DR25D9302, an indefinite delivery contract.
Was contract SPE2DR26FBPEC competed?
The extent of competition for SPE2DR26FBPEC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award